Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Condition: Ulcerative Colitis · Sponsor: Alfasigma S.p.A.
About this study
The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in ulcerative colitis (UC).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (323)
| Digestive Health Specialists Of The Southeast | Dothan, Alabama, United States | — |
| Mayo Clinic Arizona | Scottsdale, Arizona, United States | — |
| VA Long Beach Healthcare System | Long Beach, California, United States | — |
| Cedars Sinai Medical Center | Los Angeles, California, United States | — |
| South Denver Gastroenterology, PC | Lone Tree, Colorado, United States | — |
| Connecticut GI PC-Research Division | Farmington, Connecticut, United States | — |
| UF Clinical Research Center | Gainesville, Florida, United States | — |
| Florida Research Institute | Lakewood Rch, Florida, United States | — |
| University of Miami Crohn's and Colitis Center | Miami, Florida, United States | — |
| Cordova Research Institute | Miami, Florida, United States | — |
| Gastroenterology Group of Naples | Naples, Florida, United States | — |
| Advanced Medical Research Center | Port Orange, Florida, United States | — |
+ 311 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02914535